• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Torrent Pharmaceuticals Ltd.
    13 Jan 2025
    Estimates Miss
    3289.00
    1.47%
    Torrent Pharma To Hold Meeting On Jan. 24 To Consider Interim Dividend
    Torrent Pharma To Hold Meeting On Jan. 24 To Consider Interim Dividend
    NDTV Profit
    The interim dividend will be for the equity shares of Rs 5 each.
    Copy LinkShare onShare on Share on Share on
    Torrent Pharmaceuticals Ltd. is trading at high day volume of 1.1M.
    logo
    Wockhardt Ltd.
    13 Jan 2025
    1341.20
    1.25%
    Wockhardt Sees New Drugs To Fight Superbugs As Next Growth Driver
    Wockhardt Sees New Drugs To Fight Superbugs As Next Growth Driver
    NDTV Profit
    Wockhardt, founded in 1967, now has six novel formulations in the pipeline, with a second drug Zaynich also expected to launch later in 2025 to tackle complex hospital infections.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 152 to 171 in Mar 2025 qtr.
    Wockhardt's Zaynich antibiotic achieves 97% efficacy against carbapenem-resistant bacteria
    Business Line | 13 Jan 2025 2 more
    Wockhardt gains 4% as drug shows 97% efficacy for drug-resistant bacteria
    Business Standard | 13 Jan 2025
    Wockhardt shares jump 4% despite stock market crash. Here's why
    livemint | 13 Jan 2025
    logo
    Caplin Point Laboratories Ltd.
    13 Jan 2025
    High Gain High Volume
    2252.40
    5.90%
    Caplin Point's incredible growth: Is the best behind us?
    Business Line
    Copy LinkShare onShare on Share on Share on
    Caplin Point Laboratories Ltd. is trading at high volume of 601.6K with price gain of 5.90.
    logo
    Biocon Ltd.
    13 Jan 2025
    340.65
    2.45%
    Biocon Shares Rise Over 4% After USFDA Clearance For Malaysia Insulin Units
    Biocon Shares Rise Over 4% After USFDA Clearance For Malaysia Insulin Units
    NDTV Profit
    After the clearance from US drugs regulator, Motilal Oswal has upgraded Biocon to 'buy' with a target price of Rs 430 apiece.
    Copy LinkShare onShare on Share on Share on
    Biocon Ltd. has an average target of 389.25 from 4 brokers.
    Biocon share price jumps over 4% after US FDA clears Malaysian insulin facility
    livemint | 13 Jan 2025 1 more
    Biocon Gets Motilal Oswal's 'Buy' Upgrade On U.S. FDA Clearance For Malaysian Site
    NDTV Profit | 13 Jan 2025
    logo
    Dr. Reddy's Laboratories Ltd.
    13 Jan 2025
    1224.70
    0.04%
    Dr Reddy Share Price Live blog for 13 Jan 2025
    Dr Reddy Share Price Live blog for 13 Jan 2025
    livemint
    Dr Reddy Share Price Today Live Updates : Dr Reddy stock price went down today, 13 Jan 2025, by -1.27 %. The stock closed at 1371.6 per share. The stock is currently trading at 1354.2 per share. Investors should monitor Dr Reddy stock price closely in the coming days and weeks to see how it reacts to the news.
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laboratories Ltd. is trading above its 100 day SMA of 1210.4
    logo
    Sun Pharmaceutical Industries Ltd.
    11 Jan 2025
    Board Meeting
    1731.80
    1.41%
    Sun anchors its speciality business
    Business Line
    From branded generics to speciality-driven growth, Sun Pharma is preparing for the long haul
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 1310 to 1351 in Mar 2025 qtr.
    logo
    Windlas Biotech Ltd.
    10 Jan 2025
    Board Meeting
    956.20
    0.97%
    Windlas Biotech's injectable facility gets GMP certification
    Business Line
    The certification by Uttarakhand's Food Safety & Drugs Administration Authority confirms the facility's compliance with WHO TRS Guidelines
    Copy LinkShare onShare on Share on Share on
    Windlas Biotech Ltd. is trading below its 30 day SMA of 988.3
    logo
    Dr. Reddy's Laboratories Ltd.
    10 Jan 2025
    1224.70
    0.04%
    Can Dr Reddy's shrug off Revlimid's patent expiry?
    Can Dr Reddy's shrug off Revlimid's patent expiry?
    livemint
    DRL also faces headwinds because of increasing competitive intensity in the generic market and exchange rate volatility.
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laborato.. has an average target of 1357.00 from 9 brokers.
    logo
    Lupin Ltd.
    09 Jan 2025
    1996.00
    1.48%
    Lupin Inks Share Subscription Agreement With Sunsure Solar Park To Acquire Upto 42.61%
    Lupin Inks Share Subscription Agreement With Sunsure Solar Park To Acquire Upto 42.61%
    NDTV Profit
    The deal is to be completed in two tranches, in the capacity as a captive user.
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd. is trading below all available SMAs
    Lupin shares gain as Pithampur manufacturing facility gets EIR from USFDA
    Business Standard | 09 Jan 2025 1 more
    Lupin gets clearance from USFDA for its Pithampur manufacturing facility
    Business Standard | 08 Jan 2025
    logo
    Lupin Ltd.
    09 Jan 2025
    1996.00
    1.48%
    Lupin Receives Tentative USFDA Approval For Generic Ivacaftor Oral Granules
    Lupin Receives Tentative USFDA Approval For Generic Ivacaftor Oral Granules
    NDTV Profit
    These generic granules are equivalent to Vertex Pharmaceuticals' 'Kalydeco' oral granules in the same strengths.
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd. has an average target of 2329.44 from 9 brokers.
    Lupin receives US FDA tentative approval for Ivacaftor Oral Granules
    Business Standard | 09 Jan 2025
    more
    loading
    Logo Trendlyne

    Stay ahead of the market

    Company

    PrivacyDisclaimerTerms of Use Contact Us

    Resources

    Blog FAQsStock Market Widgets

    Copyright © 2025 Giskard Datatech Pvt Ltd